ROCKWELL MEDICAL, INC. Current Liabilities
ROCKWELL MEDICAL, INC. (RMTI) had Current Liabilities of $11.17 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $11.17M.
- 2026-03-31: Liabilities, Current $9.87M.
- 2025-12-31: Liabilities, Current $9.58M.
- 2025-09-30: Liabilities, Current $9.58M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $11.17M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $9.87M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $9.58M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $9.58M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $10.95M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $11.21M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $14.09M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $14.18M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $14.89M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $14.95M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $16.64M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $21.41M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $17.45M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $15.07M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $17.69M 10-K · filed 2024-03-21 | |
| 2022-09-30 | $19.34M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $18.54M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $19.59M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $20.97M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $21.76M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $34.04M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $11.23M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $12.79M 10-K · filed 2022-04-08 | |
| 2020-09-30 | $12.71M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $11.50M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $13.36M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $12.37M 10-K · filed 2021-03-31 | $12.37M 10-K · filed 2020-03-17 |
| 2019-09-30 | $12.39M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $14.83M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $15.73M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $13.20M 10-K · filed 2020-03-17 | |
| 2018-09-30 | $12.69M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $11.23M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $9.72M 10-Q/A · filed 2018-08-14 | $8.44M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $9.14M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $7.62M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $7.67M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $10.39M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $10.15M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $7.31M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $9.18M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $8.01M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $8.09M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $8.47M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $7.03M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $10.34M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $9.80M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $17.28M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $15.31M 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $14.10M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $17.85M 10-K · filed 2015-03-03 | |
| 2013-09-30 | $18.07M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $16.79M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $28.47M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $26.99M 10-K · filed 2014-03-07 | |
| 2012-09-30 | $23.05M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $17.42M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $13.84M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $13.69M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $9.62M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $6.37M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $6.42M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |